Citius Pharmaceuticals (CTXR) Income from Non-Controlling Interests (2024 - 2026)
Citius Pharmaceuticals (CTXR) posted Income from Non-Controlling Interests of -$3.06 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$414,000 a year earlier.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Income from Non-Controlling Interests (2024 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income from Non-Controlling Interests at Citius Pharmaceuticals was -$11.89 million; for FY2025 (ended Sep 30, 2025), it came in at -$2.31 million.
- In prior fiscal years, Citius Pharmaceuticals' Income from Non-Controlling Interests was -$287,000 in FY2024.
- Quarterly Income from Non-Controlling Interests has run from a low of -$6.88 million in fiscal Q2 2026 to a high of -$414,000 in fiscal Q3 2025 over five years.
- According to Business Quant data, Income from Non-Controlling Interests for the three prior fiscal quarters was -$6.88 million (Q2 2026), -$1.17 million (Q1 2026) and -$784,358 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Citius Pharmaceuticals | 14.55 Mn | 23.85 Mn | 1.00 Mn | -3.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.06 Mn |
| Mar 31, 2026 | -6.88 Mn |
| Dec 31, 2025 | -1.17 Mn |
| Sep 30, 2025 | -784,358.00 |
| Jun 30, 2025 | -414,000.00 |
| Mar 31, 2025 | -595,000.00 |
| Dec 31, 2024 | -513,000.00 |
API Access
Citius Pharmaceuticals Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();